Navigation Links
New Findings Offer Systemic Solutions to Address Non-communicable Diseases (NCDs) in Low- and Middle-income Countries
Date:2/4/2013

GENEVA, February 4, 2013 /PRNewswire/ --


  • The Johns Hopkins University report identifies systemic gaps in NCD research, policy and practice
  • Offering pragmatic actions and sustainable solutions, experts cite multisectoral cooperation as vital
  • Independent research project stems from IFPMA Framework for Action on NCDs, focusing on innovation, access and affordability, prevention and health education, and partnerships

Today the Johns Hopkins University's Institute for Applied Economics, Global Health and the Study of Business Enterprise released a focused set of policy briefs that provide actionable recommendations for improving NCD policy, research and, ultimately, care. The study was commissioned by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).

The four main NCD categories - cardiovascular disease, cancer, chronic lung diseases and diabetes - kill three in five people worldwide. Nearly 80% of NCD deaths occur in low- and middle-income countries.

As part of momentum from the 2011 United Nations High Level Meeting on the Prevention and Control of NCDs, a working group of leading scholars[1] produced this collection of briefs: Addressing the Gaps in Global Policy and Research for Non-Communicable Diseases. Their findings provide decision-makers with five key areas for action: 1) strengthening supply chains, 2) accelerating regulatory convergence, 3) applying HIV/AIDS learnings to improve access to interventions, 4) restructuring primary care, and 5) promoting multisectoral action.

"We harnessed the direction given by UN Member States in the NCD Political Declaration as a springboard for action," said Sir George Alleyne , former director of the Pan American Health Organization (PAHO), and co-author of one of the briefs. "Based on this direction, our work paves a way forward to achieve better health outcomes through multisectoral and intersectoralcooperation."

Eduardo Pisani , IFPMA Director General, said, "The research-based pharmaceutical industry commissioned these briefs to generate ideas which we hope will contribute to WHO discussions and provide a path forward where our industry is best prepared to play its part with other stakeholders."

The Johns Hopkins policy briefs can be accessed (http://www.ifpma.org/resources/publications.html).

About IFPMA

--------------------------------------------------

1. Authors include:  Brian White-Guay, Lisa Smith , PrashantYadav, SoerenMattke, Margaret Kruk , Felicia Knaul , Gustavo Nigenda, Sir George Alleyne , and SaniaNishtar. Jeffrey L.Sturchio and Louis Galambos served as editors.

IFPMA represents research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry's 1.3 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.


'/>"/>
SOURCE International Federation of Pharmaceutical Manufacturers and Associations
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Proof of Concept Study Initial Findings
2. French Lifestyle Secret Finally Revealed: Lycotec Publishes Unexpected Findings on Roquefort Cheese
3. ENDECE Neural to Present Findings for Remyelination at 2013 Keystone Symposia on Multiple Sclerosis
4. New Findings Link Telehealth-Enabled Care Coordination with Reduced Mortality for Patients with Congestive Heart Failure
5. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
6. iBio Announces At-the-Market Equity Offering
7. KaloBios Pharmaceuticals Announces Pricing of Initial Public Offering
8. Keryx Biopharmaceuticals Announces Pricing of Public Offering of Common Stock
9. Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock
10. NewLink Genetics Corporation Announces Pricing of Public Offering of Common Stock
11. Contract Research Organisations offer Promise of Innovative, Safe and Effective Drug Development, Says Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2017)... 2017  A new tight-tolerance microextrusion medical tubing ... materials, is being launched by Natvar, a Tekni-Plex ... in recent years to service a wide variety ... More expensive materials such as glass and fluoropolymers ... to their ability to consistently hold tolerances. This ...
(Date:5/3/2017)... 2017  Kalorama Information notes that transplant diagnostics ... year and this is projected to continue to ... (HSCT) or bone marrow transplants require histocompatibility between ... for this task. This according to a new ... The various PCR-based methodologies, Sanger sequencing and NGS ...
(Date:5/2/2017)... NEW YORK and LONDON ... distributor of market intelligence, MarketResearch.com is pleased to announce ... Consulting AB that allows for the marketing and ... market analyses through the MarketResearch.com website. The ... access to complete product descriptions and tables of contents ...
Breaking Medicine Technology:
(Date:5/27/2017)... ... May 27, 2017 , ... Most us are familiar with ... new study from the Osteoarthritis Initiative shows that certain people who experience ... this in advance may give doctors the opportunity to treat patients before the problem ...
(Date:5/26/2017)... ... May 26, 2017 , ... Leading CEOs from ... May 30th and 31st at The Four Seasons Hotel Boston. , The ... life sciences, offering exclusive access to key decision makers who influence deal making ...
(Date:5/26/2017)... Clara, Calif. (PRWEB) , ... May 26, 2017 ... ... announces the integration of the CareFusion NOX-T3 portable sleep monitor with its Somnoware ... provides a consistent, browser-based interface for diagnostic device operations. With this platform, initializing ...
(Date:5/26/2017)... ... May 26, 2017 , ... via ... antimicrobial, mesh back 24/7 task chair specifically designed for clinical areas. Genie Copper ... thrilled to partner with Cupron® to provide customers with a game changing chair ...
(Date:5/26/2017)... ... May 26, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... focusing on the Peace Agreements being discussed by President Donald Trump and the rest ... to try to speed up peace talks in the continuous battle between Israel and ...
Breaking Medicine News(10 mins):